1. Urothelzellkarzinome ................................................................ ca. 90% 2,3
2. Plattenepithelkarzinome ........................................................... ca. 5%
3. Adenokarzinome ...................................................................... ca. 2%
4. Sarkome ................................................................................. ca. 1%
5. aus Nachbarorganen einbrechende maligne Tumore .................... ca. 1%
6. metastatische die Blase befallende maligne Tumore ................... ca. 1%
In den tropischen Ländern mit endemischer Belastung für Bilharziose, verursacht durch Schistosomiasis, verschiebt sich die Verteilung wie folgt:
1. Plattenepithelkarzinome .......................................................... ca. 71% 4,5
2. Urothelzellkarzinome ............................................................... ca. 24%
3. Adenokarzinome ..................................................................... ca. 2%
4. Sarkome ................................................................................ ca. 1%
5. aus Nachbarorganen einbrechende maligne Tumore ................... ca. 1%
6. metastatische die Blase befallende maligne Tumore .................. ca. 1%
Literaturquellen:
1. Vidyarthi, S.C. Pathology of Bladder Tumors. in Benign and malignant Tumors of the urinary bladder (ed. Maltry Emile, J.) 13-56 (Hans Huber Publishers, Bern, Stuttgart, Wien, 1971).
2. Fischer, C.G. et al. Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries. Cancer 82, 775-83 (1998).
3. Johansson, S.L. & Cohen, S.M. Epidemiology and etiology of bladder cancer. Semin.Surg.Oncol. 13, 291-298 (1997).
4. Vizcaino, A.P., Parkin, D.M., Boffetta, P. & Skinner, M.E. Bladder cancer: epidemiology and risk factors in Bulawayo, Zimbabwe. Cancer Causes Control 5, 517-522 (1994).
5. El-Aaser, A.A., El-Merzabani, M.M., Higgy, N.A. & Kader, M.M. A study on the aetiological factors of bilharzial bladder cancer in Egypt. 3. Urinary beta-glucuronidase. Eur J Cancer 15, 573-83 (1979).